lutathera
Showing 1 - 6 of 6
Neuroendocrine Tumors Trial (Lutathera)
Not yet recruiting
- Neuroendocrine Tumors
- Lutathera
- (no location specified)
Aug 9, 2023
Gastro-enteropancreatic Neuroendocrine Tumor, Neuroendocrine Tumors Trial in Iowa City (Lutathera, Azedra)
Not yet recruiting
- Gastro-enteropancreatic Neuroendocrine Tumor
- Neuroendocrine Tumors
- Lutathera
- Azedra
-
Iowa City, IowaHolden Comprehensive Cancer Center
Jul 7, 2022
Neuroendocrine Tumors, Intestinal Well Differentiated Endocrine Tumor, Progressive Disease Trial in France (Lutathera)
Recruiting
- Neuroendocrine Tumors
- +2 more
- Lutathera
-
Angers, France
- +21 more
Aug 2, 2022
Neuroendocrine Tumors Trial (Lutathera)
Not yet recruiting
- Neuroendocrine Tumors
- Lutathera
- (no location specified)
Aug 23, 2022
Gastroenteropancreatic Neuroendocrine Tumor Trial in Stanford (Lutathera, Gallium 68 Dotatate, Computed Tomography (CT))
Suspended
- Gastroenteropancreatic Neuroendocrine Tumor
- Lutathera
- +4 more
-
Stanford, CaliforniaStanford Cancer Institute Palo Alto
Sep 21, 2022
Carcinoid Heart Disease, Carcinoid Syndrome, Carcinoid Tumor Trial (Lutathera)
Not yet recruiting
- Carcinoid Heart Disease
- +2 more
- Lutathera
- (no location specified)
Aug 3, 2020